MEDIA PLANNER 2009 - Haymarket Media Group

MEDIA 

PLANNER 

2009

The essential 

resource 

for an evolving 

industry 

“What I love about MM&M is the tone and perspective that it provides. 

It’s like a trusted friend helping me make sense out of this 

dynamic industry. It is clear about its purpose to be the premier 

guide to improving the marketing communications of biopharmaceuticals 

and medical devices.” 

—Joe Shields, Consumer Product Director, Enbrel, Wyeth 

The healthcare industry is constantly changing. And 

MM&M is always right there with it, the trusted 

authority and essential resource in healthcare marketing 

for more than 40 years. As the most dynamic 

and influential sector in today’s marketing universe 

has evolved, MM&M has enhanced its coverage and 

updated its look. As always, key decision-makers rely 

on MM&M for the timeliest news and information as 

well as the tools and strategies they need to reach their 

customers. But more than ever, today’s MM&M offers 

readers a 360-degree view of the entire medical marketing 

and media space, across multiple channels, with 

an integrated mindset and an eye toward the future. 

Whether you work as a product and brand manager 

or as another key decision-maker in the healthcare 

marketing communications field, you’ll find out about 

the latest trends that impact your business, across all 

channels. From the latest advances in closed-loop 

marketing, expert advice on patient compliance or 

advances with digital marketing, MM&M provides the 

expert reporting and keen insight your business needs 

to thrive.

THE BRAND 

14,750 qualified subscribers 

Over 23,000 unique visitors 

Medical Marketing & Media (a division of Haymarket 

Media, Inc) offers a comprehensive resource of balanced 

and relevant editorial to leaders, thinkers, marketers 

and creative executives involved in every aspect of the 

healthcare marketing industry. Through a combination 

of news, analysis, opinion, feature stories and reports, 

MM&M arms its readers with the tools they need to 

make crucial decisions in this dynamic and highly complex 

market. 

At the heart of the brand is the quality monthly print 

title, MM&M, first published in 1966. Editorial topics run 

the full gamut of medical marketing, including advertising, 

public relations, direct marketing, government 

regulation, marketing research and media. Content is 

accurate, balanced, relevant and digestible, and packaged 

with a high design value. Throughout the year, 

annual surveys, special reports and themed issues deliver 

important analysis and fresh insight, providing decisionmakers 

with invaluable reference tools. 

Complementing the print edition is the online 

property, mmm-online, featuring daily news stories and 

archived articles; twice weekly electronic newsletter, 

MM&M NewsBrief, which is emailed to subscribers; 

webcasts which engage and interact with an attentive 

audience; podcasts; custom research; and the industry’s 

definitive annual awards program, The MM&M Awards. 

An advisory board of seasoned experts, representing 

all areas of the medical marketing space ensures that the 

MM&M finger is firmly on the pulse of the industry. 

DID YOU KNOW...? 

• MM&M was first published in 1966, which makes us by far the 

longest-established trade publication in the healthcare marketing 

space. Compare with Pharmaceutical Executive (launched 1981) 

Med Ad News (1982) and PharmaVoice (2001). 

• MM&M caters mainly for pharmaceutical executives, accounting 

for almost two-thirds of our circulation (63%). Furthermore, 

between six and nine MM&M front covers each year feature 

senior pharmaceutical executives. The credibility we gain from 

our quality editorial coverage enables us to continue growing our 

alliances with client-side marketers. 

• MM&M publishes daily news at mmm-online.com and each 

story is written by a journalist — we never reproduce press 

releases. 

• In just five years, the MM&M Awards have become by far the 

biggest and best in the industry, with a record-high 830 submissions 

in 2008 and 800 guests attending the gala presentation 

event. You cannot buy an MM&M Award. All submissions are 

judged—not by us—but by 45-50 of the finest leaders and 

thinkers from across the industry, including numerous senior 

executives at pharmaceutical companies and agency CEOs.

Portfolio 

PRINT 

These Feature Department Pages Are 

Standard Editorial Sections In Each Issue… 

• CME Report 

News and analysis from the medical education sector, 

one of the most robust businesses within medical 

marketing. 

• Digital Marketing 

An in-depth analysis and commentary on the month’s 

important news stories, along with expert opinion on 

the electronic space in Web Watch. 

• Direct Marketing 

A look at the people, firms and creative work at the 

leading edge of pharma direct marketing, including 

both consumer and physician marketing campaigns. 

• DTC Report 

An update from the direct-to-consumer marketing 

arena, with analysis of spending trends and major 

account activity. 

• Marketing Research 

The latest news, trends and innovations from the pharma 

marketing research sector. Also featuring Vantage 

Point, a big picture look at marketing research issues. 

• Media Forum 

Leaders from media, marketing and medical education 

offer their unvarnished opinions on a wide range of 

topics that impact media owners and buyers/planners. 

• Media Notepad 

The industry’s most thorough and up-to-date coverage 

of medical journals and other healthcare media, along 

with a physician’s spotlight on a selected journal. 

• Public Relations 

We review recent PR initiatives and offer commentary 

from top practitioners, representing both client and 

agency perspectives. 

MEDIA FORUM 

Balancing messages on- and offl ine 

Effective patient marketing campaigns utilize traditional DTC as well as social networks and other 

emerging media online. How do marketers fi nd the right media balance? 

Eileen O’Brien 

Buddy Scalera, 

Brian Kaiser 

Michael Dennelly 

Dir., online promotions, VP, interactive content & VP, direct-to-patient, 

VP, director of digital market- 

Compass Healthcare Comms market research, Qi Interactive Targetbase 

ing, G2 direct & digital 

The real question is: how do There’s a high trust factor in Dialogue-intensive environ- W e need to start by accept- 

I best reach and convert my peer networks, so communiments such as social media ing some cold, hard facts 

target audiences? Interactive cating through word-of-mouth do not conform to traditional that the industry is facing: 

marketing, social networks yields strong results. As mar- campaign architecture. Mar- patients increasingly don’t 

and other emerging media just keters, we want our brand keters are learning how to trust pharma DTC. DTC 

provide additional channels voice to be part of this dia- engage in an “always on” effectiveness is seriously under 

for marketers to accomplish logue, so dollars have moved conversation with patients question and patients are 

their objectives. The right to MySpace, Facebook and that lacks a beginning and end. now shaping the discussions 

media balance is infl uenced YouTube. Like websites, social Social networks should be around brands online. With 

by a variety of factors, includ- networks are measurable and approached as a form of this in mind, the key to fi nding 

how niche the audience is, offer an attractive cost per relationship marketing. Finding the right media balance 

brand resources, and whether acquisition. But remember; ing the right balance begins is to cast aside tradition, such 

broad awareness or specifi c only a portion of life is spent with defi ning what type of as spending the lion’s share 

conversions are desired. For online. People are still exposed relationship the brand wants of media dollars on DTC and 

example, Lipitor with its need to print, TV, radio and direct to cultivate with a given start understanding better how 

to reach a broad audience with mail. It’s too early to abandon audience, then supporting and when patients make their 

simple brand messages would DTC because it still plays a continuity of the experience healthcare decisions. Then you 

have a very different mix of powerful role in driving brand as the patient moves chan- can use these insights strategi- 

media than a specialty drug awareness and interest. Online nel to channel. The question cally as your guide. You need 

looking to reach disparate competition has made DTC mark for marketers is whether to engage your patients in an 

patients with a complicated rates more competitive, lower- the brand is equipped with ongoing, valuable and credible 

story. With specifi c regard to ing barriers for niche brands. tools and strategies to rapidly dialogue. Believe me, they will 

social media, it’s important to Now we see integrated cam- interpret information shared let you know where to reach 

identify if your target audience paigns that work synergisti- by the patient and generate a them—you just have to listen. 

is using these networks and cally to maximize both social relevant response. Effective 

receptive to hearing your mes- networks and DTC. 

patient marketing depends on Got a forum question or comment? 

sage via these channels before 

this ability to communicate at E-mail us at ben.comer@ 

embarking on a campaign. 

relationship speed. 

haymarketmedia.com 

The key to fi nding the right balance is to cast aside tradition, 

such as spending the lion’s share of media dollars on DTC 

20 MM&M OCTOBER 2008 mmm-online.com 

“ 

PUBLIC RELATIONS 

PR View 

BY DIANE WEISER 

This year has not been kind to biopharmaceutical 

companies. The FDA 

has rejected or delayed some of the most-anticipated 

drugs. Safety and data concerns have decimated sales 

of once high-fl ying cholesterol, anemia and diabetes 

drugs. And, simultaneously, traditional pathways of 

communication with patients and doctors—DTC, 

detailing, CME—have come under greater scrutiny. 

Surviving in such an environment requires an even 

higher level of transparency , and PR plays a vital 

role. In such situations, companies should recognize 

the different stakeholders that have an interest and 

tailor communication to each group: 

Physicians: Doctors are, by nature, data hounds. 

The more detail that can be provided, the better. 

Patients: PR messages 

Fully detailing should be aligned with 

study results and larger marketing and 

actions may mean advertising messages so 

short-term pain that outreach can be con- 

but it builds a rep sistent in tone. 

for disclosure Media and Investors: 

Fully detailing study 

results and regulatory actions may mean short-term 

pain but it builds a rep for disclosure. 

Advocates: Third-party groups play an essential 

role in translating the news for their members. Having 

them prepared for news helps solidify those relationships 

and helps ensure continued partnership. 

Still, openness is not a panacea. The development 

process will always be marked by failures. But full 

disclosure to all affected groups can limit the damage 

of a negative event and help build corporate rep. 

Diane Weiser is president & COO, WeissComm Partners 


Fleishman-Hillard wins 

Siemens assignment 

FLEISHMAN-HILLARD has Fleishman-Hillard was up 

won an AOR assignment for against “a number of agencies” 

Siemens Medical System’s A G ’s in the pitch, according to Lon- 

global health division. 

gwell. Coyne Public Relations 

According to Lance Longwell, was the previous AOR for Sie- 

director of public relations at mens Medical Solutions. 

Siemens Medical Solutions’ US Fleishman-Hillard’s respon- 

office, the decision was based sibilities on the account will 

on Fleishman-Hillard’s “broad, include media relations and 

integrated approach, their com- campaign management across 

mand of the business issues in the Siemens Healthcare port- 

healthcare and the global footfolio, which consists of “imaging 

print they deliver. ” Terms of the and lab diagnostics, therapy and 

deal were not disclosed. healthcare information technology 

solutions , supplemented by 

consulting and support services , ” 

according to Longwell. 

Headquartered in St. Louis, 

Ohio, Fleishman-Hillard’s international 

network of 80 offi ces 

covers North America, Europe, 

Asia Pacific, the Middle East, 

South Africa and Latin America. 

Matthew Doering, SVP and 

Fleishman-Hillard’s approach senior partner, will lead the 

helped seal Siemens AOR bid account. —Ben Comer 

Senetek PLC taps Michael Rogers PR 

Senetek PLC, a life sciences physicians, as well as a consumer 

company focused on anti-aging campaign,” he said, noting that 

technologies , has tapped Michael beauty editors will be targeted, 

Rogers PR for the launch of its and a forum will be created 

Pyratine-6 product. Terms of the where women can try the prod- 

deal were not disclosed. uct and blog about it. 

Michael Rogers PR will be Pyratine-6 is Senetek’s sec- 

responsible for corporate posiond generation cytokinin-based 

tioning, physician outreach and skincare treatment used to com- 

consumer education. “Our target bat the signs of aging. Senetek 

is women 40 years and older,” developed the Kinerase skin- 

said Michael Rogers , president. care line in the 1990s . Pyratine-6 

“We’ll do some advertising in does not require a prescription, 

the trades to start, and we’re cre- although it can not be purchased 

ating an education campaign for directly in a pharmacy . —BC 

 

 

 

DTC REPORT 

Update 

DTC Perspectives 

named four to its DTC 

Hall of Fame. They are: 

Merck’s Len Tacconi, 

who established 

the 

company’s 

consumer 

marketing 

function; Ed 

Slaughter, who helped 

create the Prevention 

survey of Consumer 

Reaction to DTC Advertising; 

legal eagle 

Jim Davidson (above), 

who was instrumental 

in fending off new DTC 

regulation; and Common- 

Health’s Matt Giegerich, 

who presided over the 

launch of Claritin. 

An HHS OIG report 

on the oversight of 

marketing materials for 

Part D found that 85% 

do not meet Centers for 

Medicare and Medicaid 

Services criteria. Sen. 

Herb Kohl blasted the 

agency and insurance 

companies, which he 

said “must be held to 

these standards of clarity 

and accuracy so that seniors 

can choose a Medicare 

Part D plan from the 

overwhelming number of 

those available.” 

Merck KGaA tapped 

TBWA to handle global 

communications for 

three of its consumer 

healthcare brands: Nasivin, 

Femibion and Flexagil. 

The campaigns will debut 

globally in 2009. 

The Women’s Healthcare 

Television Network, 

an advertising-supported 

in-offi ce network targeting 

women visiting OB/ 

GYN docs, was launched 

by CARE Media Holdings. 


DIGIT A L MARKETING 

Web Watch 

BY DAN MCKILLEN 


Ads in Canada had little impact: study 

A STUDY OF how DTC TV 

advertising impacted different 

populations in Canada suggested 

that ads may have little impact 

on consumers. 

The study, by Harvard Medical 

School researchers, looked 

at the impact of three big TV 

campaigns—for Nasonex, Enbrel 

and Zelnorm—on English- and 

French-speaking Canadians , the 

idea being that those for whom 

French was the primary language 

would be largely insulated 

from ads appearing on Englishlanguage 

American TV. Cam- Ads for Nasonex and Enbrel didn’t move scripts in Canada 

paigns for Nasonex and Enbrel 

didn’t even move the needle in (Zelnorm), a drug later with- DTC advertising is banned in 

the number of filled prescripdrawn owing to safety concerns , ” Canada, but Statistics Canada, 

tions between the populations the study concluded. “The impact they noted, “estimates that 

per capita, and Zelnorm ads of [DTC] advertising on drug use around 30% of TV watched by 

prompted only a brief bump in seems to be highly variable and English-speaking Canadians is 

usage among English speakers. probably depends on the char- foreign sourced,” most of that 

“Exposure to US [DTC] acteristics of the advertised drug, from the US. 

advertising transiently influ- the level of exposure to direct to The study appeared Sept. 2 in 

enced both Canadian and US consumer advertising and the the British Medical Journal. 

prescribing rates for tegaserod cultural context.” 

—Matthew Arnold 

FDA posts DTC 

guide on its site 

PFIZER RESUMED DTC advertising for its blockbuster 

statin drug, Lipitor, replacing controversial pitchman Dr. 

Robert Jarvik with an everyman approach. In the new print 

and TV ads, which broke in September, the patient says: 

“Talk about a wake-up call. I had a heart attack at 57. I 

should have been doing more for my high cholesterol. I 

learned the hard way. Now I trust my heart to Lipitor.” The 

tagline of the campaign, by Kaplan Thaler Group, is “A 

Lipitor heart-to-heart.” —Anthony Vecchione 

FDA posted a guide to drug 

advertising on its site for consumers, 

Be smart about prescription 

drug advertising. The 

site advises readers to contact 

DDMAC if they think an ad 

violates the law. 

“People are often confused 

about DTC advertising, which 

is one of the most controversial 

areas of pharmaceutical marketing,” 

said Michael Shaw, executive 

director of EthicAd, which 

developed the site. “FDA ’s new 

website helps clarify the issues 

by outlining the different types 

of DTC advertising, explaining 

what information people should 

expect to see in DTC ads and 

what additional information they 

should seek out about advertised 

products.” —MA 

CapMed: health records 

are not created equal 

Physicians are busy. Perhaps all sales, 

marketing, advertising and commu- CONSUMER personal health ture FDA updates, drug recalls, 

nications directed at doctors should be constructed records (PHR) are more than adherence reminders and formu- 

just a storage space for eleclary information, said Angst. 

with this thought in mind. The web has become the 

tronic health records. 

CapMed offers a variety of 

ultimate time saver for physicians. According to a 

According to Wendy Angst, PHRs that can be delivered 

recent Manhattan Research study, 84% of US physi- general manager at CapMed, a online and to mobile phones. 

provider of interactive personal Additionally, the company marcians 

are now online daily. 

health records, there are two kets a portable USB drive, or 

This year’s survey found that physicians desire 

major groups of PHRs: tethered Personal HealthKey, that offers 

to receive the majority of their pharmaceutical and and untethered. “The untethered patients the ability to carry a 

model belongs to the consumer, ” PHR with them on a key ring. 

device product information through online and other 

explained Angst, compared with CapMed also offers branded 

electronic sources. Currently, doctors conduct 41% of the tethered PHR that is tied to PHRs, and has partnered with 

their pharma research online. 

a product or an insurance plan. Carr Drugs and provided soft- 

The untethered, consumerware for Microsoft’s HealthVault. 

“This trend could prove to be an opportunity for 

centric model allows patients From an advertising stand- 

smaller and targeted specialty pharmaceutical and to make their own decisions point, Angst said CapMed is 

biotech companies to gain ground on larger com- about what kinds of informa- able to insert promo matepetitors 

in physician 

tion is included in a PHR, and rials into PHRs, which 

how it’s shared. “The individual could prove valuable 

Physicians save reach and market share [patient] can grant access to all in a drug launch. 

time by accessing through cost effective or part of the PHR information,” —Ben Comer 

information online digital sales and market- said Angst. For instance , patients 

can allow a spouse or a specialist 

only when they ing support strategies,” to view specifi c content—and set 

need it. After all, says Mark Bard, Manhat- limitations. 

doctors are busy tan Research president. “ A patient could elect to share 

just dermatological informa- 

“Digital channels have tion, for example, ” noted Angst. 

leveled the playing fi eld in many industries, giving In addition to medical histo- 

The PHR makes 

sales and marketing groups the chance to make a big ries and emergency information, 

health records 

PHRs can be customized to fea- 

easily portable 

impact even with limited—yet targeted—resources.” 

Physicians simply fi nd it easier and faster to conduct 

the majority of their research online. More doc- SearchMedica adds new component 

tors are reading journals and attending conferences 

SEARCHMEDICA.COM, a third-party payors and coding, ” 

online. Both of these activities have been growing at free search engine for physi- said Cyndy Finnie, senior prod- 

a double-digit rate since 2005. During this period, cians and medical practioners, uct manager for SearchMedica, 

has launched a new practice in a statement. 

physician readerships of offl ine journals and atten- 

management category. 

“The resources available 

dance at offl ine conferences have declined. 

The new category will provide through SearchMedica’s Prac- 

Physicians participating in the study say they will fi nancial, legal and administratice Management search catetive 

resources and content in an gory help practice managers… 

increase the amount of time they spend reading 

effort to address the everyday allowing them to focus more of 

online journals in the coming years. 

challenges of running a success- their time and energy on patient 

In the long run, physicians save time by accessing ful medical practice, according to care,” she said. 

this information online only when they need it. After 

a company spokesperson. SearchMedica allows adver- 

“Doctors who use Search-tisers 

to target specific search 

all, doctors are busy. 

Medica tell us about the chal- categories and pairs contextual 

Dan McKillen is the CEO of the HealthDay news service lenges of running a medical ads as well as side banners with 

practice, such as dealing with search results. —BC 

MM&M is the only industry journal I read cover to cover each month, 

and the on-line daily briefing of key events that affect our industry is 

essential for me to never be surprised by a question from any audience 

I speak to about the Value of Medicine and our industry. 

— Mike Pucci, VP External Advocacy, GlaxoSmithKline

Portfolio 

EDITORIAL CALENDAR 

While News and the Department pages are the cornerstones 

of MM&M’s editorial mix, each issue has its own 

topic-centric theme around which features are published. 

Issue feature themes include: 

JANUARY 

MM&M All-Stars 2009 

Editorial picks for Company, Agency, Media Brand and 

Large/Small Marketing Teams of the Year. 

FEBRUARY 

Direct Marketing Report 

The latest trends, insights and significant campaigns in the 

pharmaceutical direct marketing space. 

MARCH 

Sales Force Report 

Pharma sales forces are continuing to find ways to be 

smaller and work smarter. We review the key stories 

and trends. 

APRIL 

DTC Outlook 

How the changing consumer marketplace is affecting 

DTC budget allocation. We report on the latest data 

and trends. 

MAY 

The Pharma Report 

Information and insights on the top biopharma companies, 

plus all the latest Rx and sales data for the top brands and 

classes. 

JUNE 

The Global Report 

Special coverage on key overseas drug markets, along with 

a guide to researching and executing global campaigns. 

JULY 

The Agency Issue 

Independent profiles of the top agencies, plus our 

annual A-to-Z of agency contacts, rosters and 

examples of best ads. 

AUGUST 

Medical Education Report 

Extensive review of stories and trends with expert insights. 

Plus a directory of medical education companies. 

SEPTEMBER 

The Career Issue 

The 23rd Career & Salary Survey offers the latest data on 

pay, benefits, job satisfaction, migration and motivation. 

OCTOBER 

Patient Marketing Report 

The continued search for patient compliance and 

education Health 2.0, using digital, CRM, point-of-care 

and direct marketing efforts. 

NOVEMBER 

Sales Force Report 

The latest stories, data and trends in pharma sales. Plus 

our annual directory of sales support companies. 

DECEMBER 

Outlook 2010 

Commentary and predictions for almost every corner of 

pharma marketing. Plus our extensive annual pipeline 

report.

Portfolio 

ONLINE 

• Daily news 

Timely news is posted daily by MM&M’s beat 

reporters. Up to five new news stories posted 

daily—all editorially written, never regurgitated 

press releases. 

• News Brief 

MM&M News Brief is what pharmaceutical and 

healthcare marketing professionals depend on to 

keep up with industry news, the latest features, people 

moves and events. Every Tuesday and Thursday, it 

is delivered directly to the inbox of 12,500 industry 

professionals. 

• Consumer Brief 

A roundup of stories from mmm-online.com covering 

DTC advertising, patient marketing, patient education 

and regulatory issues across all consumer media 

channels—broadcast, print, interactive, direct marketing, 

PR—plus business stories relating to consumer 

marketing, such as account wins and key hires. This 

newsletter, delivered every Wednesday, acts as a 

resource for marketers, featuring links to key reports 

published by MM&M, such as the DTC Outlook and 

the Patient Marketing Report. 

• Podcasts 

MM&M’s podcasts feature interviews with industry 

leaders, features on current events, special content in 

partnership with leading marketers and agencies, and 

extended content from the print magazine. 

• Webcasts 

Throughout the year, MM&M’s senior editors address 

cutting-edge marketing topics in one-hour web events. 

Editors are joined by industry experts in a live interactive 

presentation and discussion.

CIRCULATION 

The Essential Force in an Evolving Industry 

• MM&M has nearly 34,000 active monthly readers 

(includes pass along rate)† 

• 100% of circulation is one-year qualified and 

requested* 

• Average time spent reading a typical issue of 

MM&M—41 minutes† 

• Pass along rate of 1.3 (not including subscriber) 

per copy† 

• Qualified audience – Average number of years 

worked in the pharma industry: 8 years† 

Purchasing Power 

• 92% of MM&M readers have purchasing 

involvement of a product or service† 

• 68% of MM&M readers have direct control of 

marketing budget, with the average size of the 

budget at $3 million† MM&M’s circulation breakdown 

CPM (Cost Per Thousand) 

Publication Total 1xP4C CPM 

Circulation* Gross Rate 

MM&M 14,750 $7,214 $489.08 

Pharma Exec 18,000 $8,245 $458.06 

Med Ad News 16,630 $8,313 $499.88 

Publication 1-Yr. Qualified 1xP4C CPM 

Circulation* Gross Rate 

MM&M 14,750 $7,214 $489.08 

Pharma Exec 14,218 $8,245 $579.90 

Med Ad News 10,046 $8,313 $827.49 

†Source: 2007 Mark Clements Readership Study 

*Source: 2007 December 2007 BPA Statement 

Business & Industry Total Percent 

Qualified of Total 

Healthcare Manufacturers 

(including Pharmaceutical, Device, 

Diagnostic, Equipment and 

Product Companies) 9,188 62% 

Advertising Agencies 3582 24% 

Publishers, Publishers Reps 

& Non-Journal/Desktop Media 1046 7% 

Service/Support Companies 

including Market Research, Direct 

Mail, Consultants, Creative/Desgin 

and Public Relations 730 5% 

Others Alllied to the Field 204 1% 

TOTAL 14,750 100% 


List rental information contact: 

Postal: Michael Costantino 

Ph: 845-731-2748, michael.costantino@edithroman.com 

Email: Wayne Nagrowski 

Ph: 845-731-3854, wayne.nagrowski@epostdirect.com 

2. Advertising 

Agencies 

3. Publishers, 

Publishers Reps 

& Non-Journal/ 

Desktop Media 

4. Service/Support Companies 

including Market Research, 

Direct Mail, Consultants, 

Creative/Desgin and Public 

Relations 

Other 1% 

24% 

7% 


5% 

62% 

1. Healthcare Manufacturers 

(including Pharmaceutical, 

Device, Diagnostic, Equipment 

and Product Companies)

PRINT— Placements that 

raise visibility 

Display—Branding Alongside 

Renowned Editorial 

A major objective for companies working with MM&M 

is to raise their profile and branding in the pharma 

marketplace. Print advertising is an effective component 

for achieving this objective. MM&M provides a credible 

and highly respected environment in which to promote 

the brands and capabilities. This recognition within the 

industry has enabled us to establish an audience that 

relies on MM&M to educate and update them on crucial 

developments and trends. 

PMD—Your Complete Industry Rolodex 

The Pharmaceutical Marketers Directory is the standard 

of excellence in the healthcare industry as the chosen 

resource of information for over 30 years. The PMD is 

the directory of choice with comprehensive and verified 

information on products, influential decision-makers, 

companies, agencies and suppliers to the pharmaceutical 

and healthcare industry. 

Careers Section—Targeted Access to 

Top Industry Talent 

Hiring is one of the most critical issue facing the industry 

today. MM&M’s Careers Section provides you with 

access to those hard to reach candidates that are already 

working in the industry. They are already reading 

MM&M and the Careers Section in order to keep up on 

the latest people, news and expert advice from leading 

career professionals. 

Resource Guide—Response Driven 

Exposure to New Business 

The Resource Guide offers the most cost-effective 

access to key decision-makers, ensuring a presence in 

RESOURCE GUIDE 

Ad Displays 

Am e r i c a ’ s C h o i c e 

F o r I n - S t o c k a n d 

Custom 

A d v e r t i s i n g D i s p l a y s 

Custom 

Designs 

C o u n t e r D i s p l a y s 

d i s p l a y s 2 g o . c o 

m 

102 MM&M SEPTEMBER 2007 

Promotional Products 

Anatomical Models Direct Marketing Direct Marketing Product/Rebate Vouchers 

Market Research 

Medical Education 

The industry’s most advanced 

integrated direct marketing and 

PDMA compliant fulfillment service. 

J. Knipper & Company is a Healthcare 

Marketing support services company 

offering a broad array of solutions, 

including direct-mail, fulfillment, sampling, 

database management, recalls, 

and crisis management. Supporting its 

mission of high quality, the company 

operates under the FDA’s Good 

Manufacturing Practices and uses Six- 

Sigma methods to measure and 

enhance performance. The temperature/humidity-controlled 

180,000 sq. ft. 

facility is FDA and DEA registered and 

approved to handle prescription and 

narcotic pharmaceuticals. 

Direct Marketing Direct Marketing 

MEDICAL 

Intelligent Sampling 

S i g n 

Frame 

MARKETING 

SERVICE 

Pinpointing Your Perfect 

Prospects since 1929 

Lists 

Physicians, pharmacists, 

health professionals; available 

for direct mail, broadcast fax, 

and telemarketing 

E-Mail 

Physicians, dentists, 

Trade Show 

health professionals 

Med-Pub 

Web-based controlled 

circulation management 

For more information, 

1-800-MED-LIST (633-5478) or 

sales@mmslists.com. 

www.mmslists.com 

Member HMCC, MMA, MHMA, DMA 

Order your 

June 2007/08 

PMD today! 

PMDcentral.com 

GET THE LATEST NEWS FROM 

VISIT US ON THE WEB @ 

MMM-ONLINE.COM 

SEPTEMBER 2007 MM&M 103

ONLINE ADVERTISING — Keep 

your visibility switched ON 

81,000 

page impressions/month 

23,000 

unique visitors/month 

the magazine and online. 

www.mmm-online.com—The Industry’s Daily 

News Source 

• Re-launched in May 2007, mmm-online.com has quickly 

emerged as the leading online information resource serving 

healthcare marketing executives. Our approach is to 

touch our readers in every part of their day and the web 

adds to the branding component, but it also acts as a lead 

generation tool. In such an information-driven industry it 

is essential for pharmaceutical professionals to keep up to 

date with the latest news in the industry. 

e-Newsletters – Take Your Branding 

to the Inbox 

• E-mail Marketing has quickly become one of the most 

effective mediums to communicate a marketing message. 

Industry professionals look to email services for timely 

news in a quick and bite-size format. 

Sponsored Webcasts – Engage and Interact 

With an Attentive Audience 

• Webcasts touch on all aspects of comprehensive marketing 

objectives – branding, thought leadership, education 

and lead generation. They represent an extremely effective 

channel for presenting information to an attentive 

and participatory audience, offering all the benefits 

of a personal presentation with live interaction — and 

yet, neither the presenters nor the viewers need leave 

their desks to take part. 

Sponsored Podcasts – Offer Insights 

on Demand 

• Now that downloading and playing digital audio files 

is second nature to millions of Americans, podcasts have 

become one of the most efficient channels for offering 

on-the-spot reports, interviews, insights and news updates.

SPECIAL OPPORTUNITIES — 

Delivering solutions to meet 

your needs 

Events — MM&M Awards 

As the only independent awards program serving medical 

marketing, sponsorship of the MM&M Awards offers 

an ideal complement to any integrated marketing plan. 

The MM&M Awards were designed and executed to 

communicate a great appreciation for exceptional work 

in marketing. Attendance of the awards by hundreds of 

the industry’s leaders in each of the past three years is a 

strong testament to the impact delivered by the event. 

Special Supplements 

Interactive Guide: Pharma marketer’s guide to the digital 

landscape plus a showcase of media and agency offerings 

Creative Portfolio: The definitive all-in-one creative showcase 

and contact file of healthcare advertising agencies 

Med Ed Guide: Key issues and market trends, with 

insights from prominent leaders. Plus a showcase of 

providers. 

Career Guide: Information, trends and advice on careers 

in healthcare marketing. Plus a showcase of firms looking 

for talent. 

MM&M Awards Book of the Night: Showcase of the gold 

and silver award winning campaigns from 2009, plus all 

the judges’ bios. 

Integrated product mix: 

Display Advertising 

Custom Publishing 

Website 

eNewsletters 

Webcasts 

Events 

Lists/Reprints/Research 

Brand 

Building 

Lead 

Generation 

Reprints 

Reprints enhance your marketing efforts by serving 

as a third-party testimonial from copyrighted material 

providing information in a positive and unsolicited 

manner. 

List Rental 

Reach a key group of healthcare marketing professionals 

through the MM&M print and e-Newsletter 

subscriber file. 

Sponsored Roundtable – Take a Front 

Seat in Thought Leadership 

Roundtables are a wonderful opportunity to interact 

with other industry thought leaders face-to-face and 

to be associated with the high-level expertise and 

insights that will appear in the magazine when the 

highlights of the discussion are published. 

Sponsored Survey – Address Industry 

Pain Points with Original Research 

A credible, well-executed survey represents one of 

the best ways to deliver detailed information and 

fresh trends and insights to our readers. 

Thought 

Leadership 

Education 

Relationship 

Building

ADVERTISING TERMS 

& CONDITIONS 

All orders for insertion of advertisements are accepted subject 

to the following conditions. 

1. Ordering 

1.1 Advertising orders issued by an advertising agency will 

be treated as issued by that agency as principal. Where 

copy or other instructions not constituting an official 

order are issued, they must clearly be marked at the 

head. “Copy instructions—Not an order.” 

1.2 The placing of an order for the insertion of an Adver- 

tisement shall, whether an Advertiser stipulates so 

or not, be an order subject to these conditions, and 

any conditions stipulated on the Advertiser’s order 

form or elsewhere shall be to no effect so far as they 

are in conflict with these conditions. 

2. Advertiser’s Warranty 

The Advertiser warrants that the Advertisement: 

2.1 does not contradict any act of law or subordinate 

legislation; 

2.2 is not in any way illegal or defamatory or an 

infringement of any other party’s rights; 

2.3 is legal, decent, honest and truthful; and 

2.4 is not an infringement of the American Association 

of Advertising Agencies. The Advertiser hereby agrees 

to indemnify Haymarket Media against any and all 

actions, proceedings, claims, demands, damages and 

costs (including legal costs) for breach of this warranty 

in respect of defamation, obscenity, misrepresentation 

or libel, or any other claim arising out of or in respect 

of the Advertisement or the publication or distribution 

of the Advertisement. 

3. Corrections 

3.1 Haymarket Media will not be held responsible for 

alterations or corrections to proofs, if returned after the 

specified date or not confirmed in writing. 

3.2 No responsibility is taken for the accuracy of copy not 

given in writing to Haymarket Media. 

4. Artwork, etc. 

Artwork and/or photographic materials are submitted 

to, and used by, Haymarket Media entirely at the risk 

of the person by whom, or on whose behalf, they were 

submitted. Unless otherwise arranged, Haymarket 

Media reserves the right to return or dispose of such 

artwork and/or photographic materials if not collected 

within six months of their receipt by Haymarket Media, 

and any return carriage costs must be paid by such 

person. 

5. Positions 

5.1 Special positions will be given only if agreed by 

Haymarket Media in writing and at an additional 

charge. Agreement will be specific to an identified 

advertiser. No other client of an advertising agency 

may take the position without prior written consent 

of Haymarket Media. 

5.2 Any advertisement-promoting job and or career 

opportunities must appear within the ‘Job 

Opportunities’ pages of Haymarket Media. 

6. Late Copy and / or Proofs 

If, following an accepted order for space, an 

Advertiser’s copy instructions and / or proofs are not 

received by Haymarket Medias’ copy date, Haymarket 

Media reserves the right to print any previously sup 

plied copy or from any appropriate proofs received 

from the Advertiser. 

7. Cancellations, etc. 

7.1 The Company reserves the right: 

a) to refuse or cancel any advertisement without 

giving any reason or period of notice thereof; 

b) to make corrections or alteration it considers 

necessary or desirable in an advertisement 

(whether to conform it to the style and subject matte 

of the publication or otherwise): 

c) to alter, cancel or postpone publication date(s). 

7.2 If at the time advertising space is ordered by an adver- 

tising agency that agency does not disclose: 

a) the name of its clients, and / or 

b) the product and / or services which are to be the 

subject of the Advertisement(s) for that space, 

Haymarket Media may at any time refuse or suspend 

the Advertisement(s) the agency proposes for such 

space. 

7.3 In the circumstances set out in the subclause 7.2 above 

the Advertiser—which for these purposes shall mean 

both the advertising agency and its client(s)—shall 

have no claim against Haymarket Media in respect of 

the refusal or suspension and, if the space is not filled 

by Haymarket Media, the advertising agency shall be 

responsible for any loss suffered by Haymarket Media. 

In any case under clause 7.1 above Haymarket Media 

will return any money paid by the Advertiser in 

respect of an Advertisement which does not, or Adver- 

tisements which do not appear and, in the case of an 

order for a series of Advertisements, the Advertiser will 

not be liable for the difference between the rate agreed 

for the entire series specified in the order and the usual 

rate for the number of Advertisements which has 

appeared when the cancellation occurs.

ADVERTISING TERMS 

& CONDITIONS 

7.4 Print advertisement cancellations and transfers can 

only be accepted if requested by the Advertiser in writ- 

ing, and if the request is received by Haymarket Media 

not less than 2 months before copy date in the case of 

annual or monthly publications or six weeks before 

copy date in the case of weekly publications or (in 

either case) as specified in the publication’s rate card. 

7.5 Web advertisement cancellations and transfers can 

only be accepted by the Advertiserin writing, and if 

the request is received by Haymarket Media not less 

than 1 month before the copy date. 

7.6 If an Advertiser cancels the balance of an order, he 

relinquishes any right to the series discount to which 

he was previously entitled, and must pay for Adver- 

tisements at the appropriate rate set out in the rate 

card for the number of advertisements which has 

appeared when the cancellation takes effect. 

8. Errors 

8.1 The Advertiser shall notify Haymarket Media in 

writing of any error in a published Advertisement 

prior (whenever practicable) to the copy date for any 

subsequent insertion of the same Advertisement and 

in any case within fourteen days of the first publication 

date. Failing such notification Haymarket Media will 

be under no liability to the Advertiser in respect of 

such errors, and the Advertiser will indemnify the 

Haymarket Media against all actions, pro-ceedings, 

claims, demands, damages and costs (including legal 

costs) brought or made by third parties as a result of 

the publication or distribution of an Advertisement 

containing such an error. 

8.2 Proofs must be passed by the Advertiser before 

insertion, if time permits. 

9. Rates and Payment 

9.1 Unless Haymarket Media agrees otherwise in writing, 

the price for any Advertisement (including any Adver- 

tisement being published as part of a series) will be the 

price (according to the relevant rate card) prevailing at 

the date of publication. 

9.2 Unless Haymarket Media agrees otherwise (in writing) 

payment is due immediately on publication. Where 

Haymarket Media allows credit it will do so (unless it 

stipulates other-wise) for 30 days from date of invoice. 

Failure to pay accounts will make advertising agencies 

liable to the following reductions in any commission 

otherwise allowed to them: 

a) 3 percent of the gross rate where the sum owing has 

not been paid on the due date: 

b) a further 2 per cent on the gross rate (making a 

total of 5 per cent) where the sum owing remains 

unpaid one month or more after the due date. 

9.3 Charges will be made to the Advertiser where the 

printers are involved in extra production because 

of exceptional production requirements or acts or 

defaults of the Advertiser. 

9.4 Not more than one voucher copy of the publication will 

be provided for each insertion, and for orders of less 

than $100 no voucher copies will be provided. In the 

case of Annual publications only tear sheets will be 

provided. 

10. Miscellaneous 

10.1 These Conditions and all other express terms of the 

contract shall be governed and construed in accordance 

with the laws of the State of New York and any disputes 

will be subject to the jurisdiction of those courts unless 

another method can be mutually agreed on. 

10.2 In these Conditions the following terms shall have the 

following respective meanings: 

“Advertiser” shall mean the Advertiser or, as the 

context requires, an advertising agency acting on behalf 

of the Advertiser. 

“Advertisement” shall include any loose or insert 

advertisement and any advertisement attached to or 

distributed with the relevant publication including 

free gifts, and advertise-ments in any form, including 

without limitation, computer or electronic readable 

form. 

“Haymarket Media” shall represent a publication of 

the Haymarket Group, Ltd. and any references made 

to Haymarket Media is understood to represent the 

Company only in its role as Publisher of Haymarket 

Media and no other properties. 

10.3 Haymarket Publishing Services Limited acts as agent 

for Haymarket Media in all matters relating to the 

invoicing and collection of receivables.

MEDIA PLANNER 2009 - Haymarket Media Group

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?